Market Place
Sourcing Support
Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
08 Aug 2024 //
BUSINESSWIRE
Ironwood Announces Publication of Linaclotide Phase III Data
08 Jan 2024 //
BUSINESSWIRE
Ironwood to Present New Data at NASPGHAN Annual Meeting
05 Oct 2023 //
BUSINESSWIRE
FDA approves first treatment for pediatric functional constipation
13 Jun 2023 //
FDA
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS
12 Jun 2023 //
BUSINESSWIRE
Ironwood Presents New Data on Potential Linaclotide for Functional in Children
08 May 2023 //
BUSINESSWIRE
Ironwood to Present New Data at Digestive Disease Week® 2023 of Linaclotide
24 Apr 2023 //
BUSINESSWIRE
Ironwood Announces Priority Review of Supplemental NDA for LINZESS
13 Feb 2023 //
BUSINESSWIRE
AbbVie Submits Supplemental NDA to U.S. FDA to Support New Indication of LINZESS
16 Dec 2022 //
PRESS RELEASE
Ironwood Pharma Reports Positive Topline Data from Phase III Trial of LINZESS
06 Sep 2022 //
BUSINESSWIRE
Ironwood Reports Q4, Full Year 2021 Results; LINZESS Achieves Blockbuster Status
17 Feb 2022 //
BUSINESSWIRE
Ironwood Announces FDA Approval of Revised LINZESS® (linaclotide) Label
26 Aug 2021 //
BUSINESSWIRE
American Journal of Gastroenterology Publishes Full Results from LINZESS Trial
16 Jun 2021 //
BUSINESSWIRE
Ironwood Announces Publication of Positive LINZESS Phase IIIb Trial in AJG
16 Jun 2021 //
BUSINESSWIRE
Ironwood Announces Agreement with Teva Involving LINZESS® (linaclotide)
26 May 2021 //
BUSINESSWIRE
Ironwood & Allergan Receive Notices of Allowance Patent Applications LINZESS®
28 Apr 2020 //
BUSINESSWIRE
Ironwood and Allergan Settles LINZESS® (linaclotide) Patent Litigation
24 Jan 2020 //
BUSINESS WIRE
Allergan keeps Linzess generics out until 2029 with Teva settlement
23 Jan 2020 //
PM LIVE
AstraZeneca amends collaboration with Ironwood Pharma for Linzess in China
19 Sep 2019 //
PHARMABIZ
AstraZeneca amends collaboration with Ironwood Pharma for Linzess in China
19 Sep 2019 //
PHARMABIZ
Ardelyx bags its first FDA OK for IBS, setting up a showdown Allergan, Ironwood
13 Sep 2019 //
ENDPTS
Ironwood, Allergan`s new Linzess data could cue much-needed prescription jump
20 Jun 2019 //
FIERCE PHARMA
Ironwood & Allergan Settlement with Mylan Resolving LINZESS® (linaclotide)
03 Jan 2019 //
BUSINESSWIRE
Product-Specific Guidance for Linaclotide; Draft Guidance for Industry
02 Jan 2019 //
FEDERAL REGISTER
Linzess (linaclotide) : Allergan, Ironwood Pharmaceuticals vs. Mylan Pharms
20 Dec 2018 //
PATENT LITIGATION
After 3 years of hunting a buyer, Trulance maker Synergy desperate for cash
26 Oct 2018 //
FIERCE PHARMA
Astellas announces approval of Linzess Tablets in Japan
30 Aug 2018 //
BIOSPECTRUM
Ironwood Initiates Phase IIIb Study of Linaclotide in Adult Patients with IBS
16 Jul 2018 //
YAHOO FINANCE
Ironwood & Allergan Announce Settlement with Aurobindo Pharma Resolving LINZESS®
03 May 2018 //
BUSINESSWIRE
Under pressure, Peter Hecht splits Ironwood into two spinning out R&D operation
01 May 2018 //
ENDPTS
Sun Pharma to end patent dispute constipation drug with Ironwood Allergan in US
18 Jan 2018 //
MONEYCONTROL
FDA Confirms Paragraph IV Patent Challenge of inzess (Linaclotide ) Capsules
04 Jan 2018 //
FDA
Toxicity knocks Ardelyx`s hyperkalemia hopes back to preclinic
21 Nov 2017 //
FIERCE BIOTECH
NICE backs Allergan`s IBS therapy Truberzi
02 Sep 2017 //
PMLIVE
Launch of LINZESS® Tablets 0.25mg in Japan
22 Mar 2017 //
PRESS RELEASE
Ironwood`s colonic delivery platform a `pipeline within a pipeline
10 Mar 2017 //
FIERCE BIOTECH
Astellas, Ironwood phIII trial of linaclotide primary endpoint
30 Jan 2017 //
PHARMABIZ
USFDA Approves 72 mcg Dose of Linzess for Adults
26 Jan 2017 //
PR NEWSWIRE
Allergan Unveils Single-Digit Price Hikes for 9 Brand Name Drugs
04 Jan 2017 //
BIOSPACE
Ironwood`s partner Astellas gets Japanese marketing nod for Linzess
21 Dec 2016 //
PHARMABIZ
Fitch Affirms Allergan at `BBB-`; Outlook Stable
08 Dec 2016 //
REUTERS
Growth pharma` Allergan misses sales, EPS marks. One-time blip, or new trend?
02 Nov 2016 //
FIERCE PHARMA
Allergan rolls out third round of Linzess ads, target patients fed up
10 Mar 2016 //
FIERCE PHARMA MARKETING
Actavis wins more hearts on Wall Street as `top 4` Morgan Stanley pick
19 May 2015 //
FIERCE PHARMA
